Probiotics and CVD: OptiBiotix extends CholBiome range to APAC as blood pressure and cholesterol concerns rise OptiBiotix Health will start distributing its blood pressure and cholesterol lowering probiotic in Asia Pacific this year, with heart health concerns rising on the back of changing dietary and lifestyle patterns in the region.
Cardiovascular disease (CVD) is the number one killer of deaths globally, and in APAC, CVD prevalence is rising in the region home to 60% of people in the world.
“
About 35% of the population in places like New Zealand, Australia and Singapore have CVD, in other areas like Thailand and Philippines, it’s about 20%,” said Stephen O Hara, chief executive at OptiBiotix Health.